Aberdeen Group
BNTX icon

Aberdeen Group’s BioNTech BNTX Stock Holding History

Aberdeen Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-44,060
Closed -$4.19M – 942
2025
Q4 		$4.19M Sell
44,060
-247,847
-85% -$25M 0.01% 716
2025
Q3 		$28.8M Sell
291,907
-430,021
-60% -$46M 0.05% 325
2025
Q2 		$76.9M Buy
721,928
+336,260
+87% +$34M 0.13% 146
2025
Q1 		$35.1M Hold
385,668
– – 0.07% 247
2024
Q4 		$43.9M Buy
385,668
+159,676
+71% +$18.2M 0.08% 225
2024
Q3 		$26.8M Buy
225,992
+173,969
+334% +$16M 0.05% 326
2024
Q2 		$4.18M Sell
52,023
-51,835
-50% -$4.74M 0.01% 655
2024
Q1 		$9.58M Hold
103,858
– – 0.02% 555
2023
Q4 		$11M Buy
+103,858
New +$10.5M 0.02% 532

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aberdeen Group's BNTX Position: Q1 2026 in Review

Aberdeen Group sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 44,060 shares — an estimated $4.19M sold.

Aberdeen Group first reported a position in BNTX in Q4 2023 and held it in 9 quarters. The position peaked at $76.9M in Q2 2025. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Aberdeen Group reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
  • Aberdeen Group sold 44,060 BioNTech shares in Q1 2026, an estimated $4.19M.
  • Aberdeen Group first reported a position in BioNTech in Q4 2023 and held it in 9 quarters.
  • Aberdeen Group's BioNTech position peaked at $76.9M in Q2 2025.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Aberdeen Group's 13F filing for Q1 2026, filed 29 Apr 2026.